http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113413457-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-14 |
| filingDate | 2021-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113413457-B |
| titleOfInvention | Application of TAX2 polypeptide in preparation of medicine for preventing and/or treating abdominal aortic aneurysm formation and/or rupture |
| abstract | The invention provides an application of TAX2 polypeptide in preparing a medicament for preventing and/or treating abdominal aortic aneurysm formation and/or rupture. The invention discloses that by supplementing TAX2 polypeptide, macrophage infiltration of abdominal aorta vessel wall, activation of matrix metalloproteinase system and apoptosis of vascular smooth muscle cell are obviously inhibited, and the risk of forming and rupturing abdominal aortic aneurysm is finally reduced. |
| priorityDate | 2021-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 166.